Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

Phase 3

Completed

• Conditions: Insomnia

• Registration Number: NCT00095069
• Lead Sponsor: H. Lundbeck A/S

Brief Summary

The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-10
• Study First Submitted: 2004-10-29
• Study First Submitted QC: 2004-10-29
• Study First Posted: 2004-11-01
• Primary Completion: 2007-02
• Study Completion: 2007-02
• Status Verified: 2015-01
• Last Update Submitted: 2015-01-13
• Last Update Posted: 2015-01-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

• Diagnosis of insomnia

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Patient-reported amount of sleep and time to fall sleep at night after three months

Secondary Outcome Measures

Name	Time	Method
Functioning after 3 months
Patient-reported awakenings at night
Sleep quality